Andrea Gordon’s Profile

Immediate Past Chair 2010-2011

After 20 years of involvement in the Lynn Sage Cancer Research Foundation, 2010 was Andrea Gordon’s time to chair the organization.  Yet it was not without some concerns about whether she would be able to contribute enough to this venerable 25-year old foundation.“Being part of this group for 20 years, I feel such a strong sense of fiduciary responsibility – to our donors, to our board members at all levels and to the organization’s original founding members – I honestly wasn’t sure I’d be able to give back as much as I felt this group needs,” says Gordon, 2010 – 2011 Chair, who has a demanding career in the legal industry in addition to her board responsibilities.

“I saw how exciting this organization is and how much work we have to do to eradicate this terrible disease and I wanted very much to be a part of continuing to make a difference.”  In the past 25 years, LSCRF has raised more than $20 million for breast cancer research and education.  During her chairmanship, Gordon is committed to increasing fund-raising efforts.  “Funding research and education is one of the most important things we can do to make a difference in the lives of so many affected people and their families,” she says.

Joining LSCRF in 1990 at the invitation of a friend who is also the nephew of Lynn Sage, Gordon later became Chair of the Junior Board, Vice Chair of the Associate Board, a member of the Executive Board, and served as both Vice Chair and Secretary of the Full Board.  “In all these years, I’ve seen so many people with deep personal ties to this organization and strong commitments to raise funds for research and educational outreach for breast cancer.  It’s inspiring and also a little intimidating,” she says.  As part of her board responsibilities, Gordon and her colleagues also must skill themselves in the science and technology of breast cancer research as part of the grant process.  “We work incredibly hard to understand the cutting-edge science that is involved in curing this disease.  It’s vitally important to be a good steward of donor funds and be rigorous in reviewing which grant proposals merit our collective investment.”